Skip to main content
Equibles

CITIGROUP INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 831001 NEW YORK, NY
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$4,932,184
+$3,429,924 QoQ
Shares Held
194,948
+188.9% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Derivatives in ACAD

reported options exposure · as of Dec 31, 2025
CallValue
$560,910
CallShares
21,000
PutValue
$560,910
PutShares
21,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. ACAD ranks #63 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 706,968 $351,172,214
2 REGN
Regeneron Pharmaceuticals, Inc.
 346,637 $216,142,034
3 MRNA
Moderna, Inc.
 2,165,414 $151,643,941
4 ROIV
Roivant Sciences Ltd.
 2,225,190 $78,749,472
5 ALNY
Alnylam Pharmaceuticals, Inc.
 227,786 $68,570,419
6 INCY
Incyte Corp
 586,431 $66,477,817
7 BBIO
BridgeBio Pharma, Inc.
 864,101 $64,358,241
8 RVMD
Revolution Medicines, Inc.
 247,052 $46,267,897

All Filings in ACAD

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,932,184 194,948
2026-03-31 $1,502,260 67,487
2025-12-31 $560,910 21,000
2025-12-31 $560,910 21,000
2025-12-31 $2,235,199 83,684
2025-09-30 $33,590,652 1,574,070
2025-06-30 $35,953,737 1,666,840
2025-06-30 $1,292,043 59,900
2025-06-30 $1,292,043 59,900
2025-03-31 $496,639 29,900
2025-03-31 $30,768,079 1,852,383
2025-03-31 $496,639 29,900
2024-12-31 $30,603,541 1,667,768
2024-09-30 $1,847,552 120,127
2024-06-30 $1,086,149 66,840
2024-03-31 $6,543,665 353,903
2023-12-31 $854,763 27,300
2023-12-31 $6,973,300 222,718
2023-12-31 $854,763 27,300
2023-09-30 $3,060,645 146,864
2023-06-30 $3,450,667 144,078
2023-03-31 $937,236 49,800
2023-03-31 $5,241,896 278,528
2023-03-31 $937,236 49,800
2022-12-31 $477,600 30,000
2022-12-31 $477,600 30,000
2022-12-31 $4,057,020 254,838
2022-09-30 $6,196,021 378,730
2022-06-30 $352,250 25,000
2022-06-30 $3,726,635 264,488
2022-06-30 $352,250 25,000
2022-03-31 $1,151,586 47,547
2022-03-31 $1,649,382 68,100
2021-12-31 $5,150,974 220,693
2021-09-30 $3,763,443 226,577
2021-06-30 $4,230,542 173,454
2021-03-31 $5,024,987 194,767
2020-12-31 $2,095,632 39,200
2020-12-31 $4,628,458 86,578
2020-12-31 $1,967,328 36,800
2020-09-30 $2,350,218 56,975
2020-09-30 $891,000 21,600
2020-09-30 $1,749,000 42,400
2020-06-30 $1,943,647 40,100
2020-06-30 $12,468,857 257,249
2020-06-30 $1,056,646 21,800
2020-03-31 $4,884,268 115,604
2020-03-31 $726,700 17,200
2020-03-31 $1,757,600 41,600